Tocqueville Asset Management L.P. Immix Biopharma, Inc. Transaction History
Tocqueville Asset Management L.P.
- $6.03 Billion
- Q1 2025
A detailed history of Tocqueville Asset Management L.P. transactions in Immix Biopharma, Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 29,300 shares of IMMX stock, worth $61,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,300
Previous 38,300
23.5%
Holding current value
$61,822
Previous $87,000
43.68%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMMX
# of Institutions
25Shares Held
3.35MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY850KShares$1.79 Million0.49% of portfolio
-
Cable Car Capital LLC San Francisco, CA779KShares$1.64 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA699KShares$1.47 Million0.0% of portfolio
-
Lynwood Capital Management Inc.405KShares$854,55011.13% of portfolio
-
Geode Capital Management, LLC Boston, MA161KShares$339,1650.0% of portfolio
About Immix Biopharma, Inc.
- Ticker IMMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,910,100
- Market Cap $29.4M
- Description
- Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specif...